美国 · 股市与财经 · Quartz
Shionogi is buying rare disease biotech IntraBio for $2 billion
The Japanese drugmaker will gain global rights to Aqneursa, a drug approved in the U.S. and E.U. for two inherited neurological disorders
在 Quartz 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (qz.com)
